Technical Program: Saturday, March 9th

Symposium Reports

7:30 AM — 12:00 PM

Registration

7:30 AM — 9:00 AM

Continental Breakfast

8:00 AM — 5:00 PM

Exhibitor Showcase, Art Exhibits

8:00 AM — 5:30 PM

Poster Viewing

8:00 AM — 8:30 AM

Welcome

Mistress of Ceremonies
Holly J. Mitchell
Vice President External Affairs,
Crystal Stairs, Inc.

Mhel Kavanaugh-Lynch, M.D, M.P.H.
Director,
California Breast Cancer Research Program

Teresa Burgess, Ph.D.
Amgen Corporation
Chair,
California Breast Cancer Research Council

8:30 AM — 10:30 AM

Plenary Discussion Session

“From Research to Action through Clinical Trials”

Moderator

Teresa Burgess, Ph.D. — Amgen Corporation
Chair, California Breast Cancer Research Council

Speakers

Zora Kramer Brown, Founder and Chair, Breast Cancer Resource Committee
Gwen Darien, Publisher and Editor-in-Chief, MAMM Magazine
Patty Delaney, Director, Cancer Liaison Program, Food and Drug Administration
Susan Honig, M.D., Medical Reviewer, Food and Drug Administration
H. Kim Lylerly, M.D., FACS, Professor of Surgery, Duke University

10:30 AM — 11:00 AM

Break

11:00 AM — 12:00 PM

Breakout Sessions 1 & 2

“Racial & Ethnic Differences in Breast Cancer”

Moderators

Lovell Jones, Ph.D.
University of Texas

Susan Shinagawa
Intercultural Cancer Council

Speakers

Determinants of Breast-Conserving Surgery in California
Cyllene Morris, DVM, MPVM, Ph.D.
California Public Health Institute

Breast Cancer Survival and Inadequate Follow-up of Abnormal Mammography: Identifying Intervention Points
Daramola Cabral, Dr.P.H., P.A.
Northern California Cancer Center

Physical Activity, Diet and Menarche in a Multiethnic Cohort
Carol Koprowski, Ph.D., R.D.
California State University, Northridge

“Biomarkers — Applications for Detection and Treatment”

Moderators

Edward Sauter, M.D. , Ph.D.
Thomas Jefferson University

Cathie Ragovin, M.D.
Massachusetts Breast Cancer Coalition

Speakers

Genomic Subtyping of Breast Cancers and Implications for Clinical Care
Stefanie Jeffrey, M.D.
Stanford University

What Integrated Histopathology is Telling Us about Molecules and Treatment
Robert Cardiff, M.D., Ph.D.
University of California, Davis

Abnormal Nipple Aspirate Fluid Cytology Indicates Increased Risk of Breast Cancer
Margaret Wrensch, M.P.H., Ph.D.
University of California, San Francisco

12:30 PM — 2:00 PM

Lunch and Keynote Address

Keynote Speaker:

“My Journey through Breast Cancer: A Story of Faith”

Faith Fancher,
KTVU Channel 2 — Ten O'clock News

2:00 PM — 3:30 PM

Breakout Sessions 3 & 4

Early Detection — Upgrading Mammography

Moderators

Cheryl Herman, M.D.
Johns Hopkins University

Joy Simha
Young Survival Coalition

Speakers

MRI for Breast Cancer Screening and Surveillance in a High-Risk Population
Nola Hylton, Ph.D.
University of California, San Francisco

New Diagnostic Techniques Using Digital Mammography
Daniel Valentino, Ph.D.
University of California,Los Angeles

Database-Aided Diagnosis of Mammograms
Jack Sklansky, Eng.Sc.D.
Charles R. Drew University of Medicine and Science

Making Progress through Collaboration

Moderators

Judith Luce, M.D.
University of California, San Francisco

Terri O'Hara
Lesbian Cancer Support Services

Speakers

Molecular Markers to Tailor Treatment to Patients
Silvia Formenti, M.D.
University of Southern California

An Antiangiogenic Agent for Breast Cancer in an Animal Model System
Francis Markland, Ph.D.
University of Southern California

Increasing Breast Health Access for Women with Disabilities
Ann Cupolo Freeman
Alta Bates Medical Center

3:30 PM — 4:30 PM

Communities and Science

3:30 PM — 5:30 PM

Poster Viewing with Presenters

Communities and Science

Presentation by the Breast Cancer Early Detection Program

CBCRP Funded Research

CBCRP Researchers will describe the posters of their latest findings

5:30 PM — 6:00 PM

Closing Remarks